A SAFETY EVALUATION AND EFFICACY OF TABLET PROSCAREHILLS IN SUBJECT OF MILD TO MODERATE BENIGN PROSTATE ENLARGEMENT

Ajitkumar Harichand Mandlecha* and Gous Shaukatali Mujawar

ABSTRACT

Introduction: Benign Prostatic Hyperplasia, which is generally abbreviated as BPH, is a disease, which is particularly seen in elderly men. It is considered as one of the major causes of lower urinary tract symptoms and bladder outflow obstruction. Among the varieties of Mutraghata, mainly Vatashteela resembles the condition of BPH. Histologically distinguishable BPH will be present in 8% of men aged 31-40 and progressively increases markedly with age to about 80% by the ninth decade of life. In India, the prevalence rate is around 50% in men above the age of 65 years. Objective: To Evaluate Safety and efficacy of Tablet Proscarehills in subject of mild to moderate Benin Prostate Enlargement. Materials and Methods: 30 subjects of mild to moderate benign prostate enlargement enrolled in the study. Conclusion: It is safe and effective in the treatment of benign prostatic hyperplasia (BPH).

Keywords: .